Stocks

The table gives an overview of all stocks, alphabetically sorted.
 C Security CSEC Apr 8, 2020 0.23 +3.59   
 C-RAD B CRADB Apr 8, 2020 32.90 +3.62   
 CAG Group CAG Apr 8, 2020 49.20 +1.44   
 Calliditas Therapeutics CALTX Apr 8, 2020 85.00 +2.41   
 Calmark B CALMAB Apr 8, 2020 5.05 -7.34   
 Camanio Care CARE Apr 8, 2020 0.34 +119.35   
 Camurus CAMX Apr 8, 2020 96.30 -0.31   
 Cantargia CANTA Apr 8, 2020 17.40 +3.69   
 Capacent Holding CAPAC Apr 8, 2020 19.30 -0.77   
 Carbiotix CRBX Apr 8, 2020 3.31 +2.80   
 Castellum CAST Apr 8, 2020 168.25 +0.45   
 Catella A CATA Apr 8, 2020 18.00 0.00   
 Catella B CATB Apr 8, 2020 18.05 +3.14   
 Catena CATE Apr 8, 2020 300.50 +1.86   
 Catena Media CTM Apr 8, 2020 18.39 +11.86   
 Cavotec SA CCC Apr 8, 2020 16.50 +0.92   
 Cell Impact B CIB Apr 8, 2020 19.56 +4.82   
 CellaVision CEVI Apr 8, 2020 277.40 +1.99   
 CELLINK B CLNKB Apr 8, 2020 91.40 -2.97   
 Cereno Scientific B CRNOB Apr 8, 2020 2.50 -0.79   
 CGit B CGITB Apr 8, 2020 43.60 +1.87   
 Challenger Mobile B CHALB Apr 8, 2020 0.04 +2.50   
 Chordate Medical Holding CMH Apr 8, 2020 0.95 +8.20   
 Christian Berner Tech Trade B CBTTB Apr 8, 2020 19.40 0.00   
 ChromoGenics CHRO Apr 8, 2020 0.18 +0.90   
 Cibus Nordic Real Estate CIBUS Apr 8, 2020 128.60 +2.06   
 Clas Ohlson B CLASB Apr 8, 2020 78.50 +2.21   
 Clavister Holding CLAV Apr 8, 2020 10.55 -0.47   
 Clean Motion CLEMO Apr 8, 2020 0.96 -4.20   
 Clemondo Group CLEM Apr 8, 2020 1.50 -9.09   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK